FDA's Social Media Guidance Skirts Questions Of Liability
"We have been hoping for some really broad-reaching guidance from the FDA. This obviously is not that document," Kaye Scholer LLP partner Lori Leskin said. “It is much more limited than what we were hoping for — are hoping for.”
To view the full article, register now.